project id: TCGA-SKCM; case submitter id: TCGA-ER-A193; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.0; rna integrity number: 7.7; age at index: 62; days to birth: -22702; days to death: 955; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1944; year of death: 2008; age at diagnosis: 22702; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T3b; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C49.0; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of head, face, and neck; synchronous malignancy: Not Reported; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2006; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 1638; days to sample procurement: 0; initial weight: 430.0; portion submitter id: TCGA-ER-A193-06A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 25.0; percent tumor cells: 75.0; percent tumor nuclei: 90.0;